BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32522710)

  • 1. A stable USPIO capable for MR lymphography with ultra-low effective dosage.
    Nie Y; Rui Y; Miao C; Li Q; Hu F; Gu H
    Nanomedicine; 2020 Oct; 29():102233. PubMed ID: 32522710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect magnetic resonance imaging lymphography identifies lymph node metastasis in rabbit pyriform sinus VX2 carcinoma using ultra-small super-paramagnetic iron oxide.
    Shen N; Tan J; Wang P; Wang J; Shi Y; Lv W; Xie X; Huang X
    PLoS One; 2014; 9(4):e94876. PubMed ID: 24733438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
    Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
    AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymph node image with ultrasmall superparamagnetic iron oxide and comparison with pathological result].
    Xue HD; Lei J; Li Z; Wang DT; Zhou WX; Dai W; Jin ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):139-45. PubMed ID: 19507589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination of benign and malignant lymph nodes at 7.0T compared to 1.5T magnetic resonance imaging using ultrasmall particles of iron oxide: a feasibility preclinical study.
    Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
    Acad Radiol; 2013 Dec; 20(12):1604-9. PubMed ID: 24200489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferumoxtran-10 MR lymphography for target definition and follow-up in a patient undergoing image-guided, dose-escalated radiotherapy of lymph nodes upon PSA relapse.
    Weidner AM; van Lin EN; Dinter DJ; Rozema T; Schoenberg SO; Wenz F; Barentsz JO; Lohr F
    Strahlenther Onkol; 2011 Mar; 187(3):206-12. PubMed ID: 21347637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
    Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
    Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-small superparamagnetic iron oxide mediated magnetic hyperthermia in treatment of neck lymph node metastasis in rabbit pyriform sinus VX2 carcinoma.
    Wang P; Xie X; Wang J; Shi Y; Shen N; Huang X
    Tumour Biol; 2015 Sep; 36(10):8035-40. PubMed ID: 25971580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
    Kimura K; Tanigawa N; Matsuki M; Nohara T; Iwamoto M; Sumiyoshi K; Tanaka S; Takahashi Y; Narumi Y
    Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.
    Heesakkers RA; Jager GJ; Hövels AM; de Hoop B; van den Bosch HC; Raat F; Witjes JA; Mulders PF; van der Kaa CH; Barentsz JO
    Radiology; 2009 May; 251(2):408-14. PubMed ID: 19401573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR relaxivity measurement of iron oxide nano-particles for MR lymphography applications.
    Firouznia K; Amirmohseni S; Guiti M; Amanpour S; Baitollahi A; Kharadmand AA; Mohagheghi MA; Oghabian MA
    Pak J Biol Sci; 2008 Feb; 11(4):607-12. PubMed ID: 18817134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USPIO-enhanced MRI of pelvic lymph nodes at 7-T: preliminary experience.
    Philips BWJ; Stijns RCH; Rietsch SHG; Brunheim S; Barentsz JO; Fortuin AS; Quick HH; Orzada S; Maas MC; Scheenen TWJ
    Eur Radiol; 2019 Dec; 29(12):6529-6538. PubMed ID: 31201525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron oxide-enhanced MR lymphography: initial experience.
    Bellin MF; Beigelman C; Precetti-Morel S
    Eur J Radiol; 2000 Jun; 34(3):257-64. PubMed ID: 10927166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging diagnosis of metastatic lymph nodes in a rabbit model: efficacy of PJY10, a new ultrasmall superparamagnetic iron oxide agent, with monodisperse iron oxide core and multiple-interaction ligands.
    Yoo RE; Choi SH; Cho HR; Jeon BS; Kwon E; Kim EG; Park J; Myeong WJ; Won JK; Lee YS; Kim JH; Park SW; Sohn CH
    PLoS One; 2014; 9(9):e107583. PubMed ID: 25216040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USPIO enhanced lymph node MRI using 3D multi-echo GRE in a rabbit model.
    Kim SH; Oh SN; Choi HS; Lee HS; Jun J; Nam Y; Lee SH; Lee JK; Lee HG
    Contrast Media Mol Imaging; 2016 Nov; 11(6):544-549. PubMed ID: 27976506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPIO-enhanced magnetic resonance imaging for the detection of metastases in sentinel nodes localized by computed tomography lymphography in patients with breast cancer.
    Motomura K; Ishitobi M; Komoike Y; Koyama H; Noguchi A; Sumino H; Kumatani Y; Inaji H; Horinouchi T; Nakanishi K
    Ann Surg Oncol; 2011 Nov; 18(12):3422-9. PubMed ID: 21607775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance lymphography of sentinel lymph nodes in patients with breast cancer using superparamagnetic iron oxide: a feasibility study.
    Shiozawa M; Kobayashi S; Sato Y; Maeshima H; Hozumi Y; Lefor AT; Kurihara K; Sata N; Yasuda Y
    Breast Cancer; 2014 Jul; 21(4):394-401. PubMed ID: 22926506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranodal signal suppression in pelvic MR lymphography of prostate cancer patients: a quantitative comparison of ferumoxtran-10 and ferumoxytol.
    Debats OA; Fortuin AS; Meijer HJ; Hambrock T; Litjens GJ; Barentsz JO; Huisman HJ
    PeerJ; 2016; 4():e2471. PubMed ID: 27781154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
    Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
    Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lymph node metastases assessment with the use of USPIO-enhanced MR imaging at 1.5 T versus 3.0 T in a rabbit model.
    Choi SH; Kim KH; Moon WK; Kim HC; Cha JH; Paik JH; Chang KH
    J Magn Reson Imaging; 2010 Jan; 31(1):134-41. PubMed ID: 20027581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.